Medicare Enrolled
Dr. Grace Kim, M.D.
Endocrinology · San Carlos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Grace Kim is an endocrinology specialist in San Carlos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 5,416 Medicare services across 1,702 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $13,841 from 51 pharmaceutical and/or device companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$13,841 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,416
Medicare services
Top 15% in CA for endocrinology
1,702
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~285 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,903 | $153 | $344 |
| Denosumab injection (Prolia/Xgeva) | 1,740 | $17 | $28 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
264 | $43 | $123 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
264 | $34 | $100 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
260 | $30 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
245 | $114 | $259 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
128 | $48 | $130 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
120 | $145 | $428 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
119 | $115 | $306 |
| New patient office visit, complex (60-74 min) | 93 | $196 | $484 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
92 | $11 | $66 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
62 | $48 | $131 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $54 | $111 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
24 | $127 | $307 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $77 | $178 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
19 | $65 | $148 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
15 | $24 | $58 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
13 | $120 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,841
Total received (2018-2024)
Avg $1,977/year across 7 years
Top 16% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
790
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,841 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,398
2023
$2,389
2022
$2,150
2021
$1,869
2020
$1,617
2019
$1,728
2018
$1,690
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$631
Novo Nordisk Inc
$386
Amgen Inc.
$332
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Bayer Healthcare Pharmaceuticals Inc.
$173
Dexcom, Inc.
$135
Madrigal Pharmaceuticals
$118
Radius Health, Inc.
$110
Alexion Pharmaceuticals, Inc.
$56
Xeris Pharmaceuticals, Inc.
$55
SANOFI-AVENTIS U.S. LLC
$51
Ascensia Diabetes Care Us Inc.
$49
AstraZeneca Pharmaceuticals LP
$35
Currax Pharmaceuticals LLC
$29
Ultragenyx Pharmaceutical Inc.
$20
Corcept Therapeutics
$19
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,690
Lilly USA, LLC
$2,343
Amgen Inc.
$1,263
AstraZeneca Pharmaceuticals LP
$615
Corcept Therapeutics
$611
Boehringer Ingelheim Pharmaceuticals, Inc.
$567
SANOFI-AVENTIS U.S. LLC
$565
Genentech USA, Inc.
$497
Dexcom, Inc.
$400
Bayer Healthcare Pharmaceuticals Inc.
$369
Alexion Pharmaceuticals, Inc.
$350
Radius Health, Inc.
$305
Xeris Pharmaceuticals, Inc.
$285
Abbott Laboratories
$284
Janssen Pharmaceuticals, Inc
$193
Merck Sharp & Dohme Corporation
$192
Amarin Pharma Inc.
$185
Novartis Pharmaceuticals Corporation
$168
Horizon Therapeutics plc
$167
Bayer HealthCare Pharmaceuticals Inc.
$167
Shire North American Group Inc
$147
IBSA Pharma Inc.
$129
Mannkind Corporation
$127
Medtronic, Inc.
$124
Madrigal Pharmaceuticals
$118
AbbVie Inc.
$109
VIVUS, Inc.
$84
Becton, Dickinson and Company
$66
Embecta Corp.
$56
Kyowa Kirin, Inc.
$55
Ascensia Diabetes Care Us Inc.
$49
Astellas Pharma US Inc
$48
Insulet Corporation
$46
Currax Pharmaceuticals LLC
$45
Ultragenyx Pharmaceutical Inc.
$44
CeQur Corporation
$38
Medtronic MiniMed, Inc.
$37
Nalpropion Pharmaceuticals LLC
$35
AbbVie, Inc.
$30
Ascendis Pharma Inc
$29
Bigfoot Biomedical Inc
$29
RECORDATI_RARE_DISEASES_INC.
$24
Tandem Diabetes Care, Inc.
$21
VIVUS LLC
$20
Regeneron Healthcare Solutions, Inc.
$20
Nalpropion Pharmaceuticals, Inc.
$18
Companion Medical, Inc.
$17
RGH Enterprises LLC
$16
LifeScan, Inc.
$15
Alfasigma USA, Inc.
$15
MannKind Corporation
$14
Top 3 companies account for 45.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Avastin · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · BEVESPI AEROSPHERE · CONTRAVE · CeQur Simplicity · Crysvita · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INVOKANA · InPen · JANUMET · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LYUMJEV · MINIMED 780G · MOUNJARO · MiniLink Real-Time Transmitter · NATPARA · NATPARA (PARATHYROID HORMONE) · Omnipod · OneTouch · Ozempic · PRALUENT · Prolia · QSYMIA · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TECENTRIQ · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Veozah · Victoza · Wegovy · XARELTO · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
125
Per 100K population
16.8
County median income
$156,000
Nearest hospital
SAN MATEO MEDICAL CENTER
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kim performed 1,903 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $13,841 from 51 companies across 790 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other endocrinologists in San Carlos?
Dr. Kim's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in San Carlos
Browse endocrinologists in San Carlos ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology